Settlement Agreements in the Biotechnology Industry
180 Contracts & Agreements
- ABEONA THERAPEUTICS INC. (1 contract)
- Adhera Therapeutics, Inc. (2)
- Advaxis, Inc. (2)
- Aimmune Therapeutics, Inc. (1)
- Alexion Pharmaceuticals (3)
- Alkermes plc. (1)
- ALNYLAM PHARMACEUTICALS, INC. (1)
- AMARILLO BIOSCIENCES INC (1)
- ANAPTYSBIO INC (1)
- Anika Therapeutics (1)
- Anixa Biosciences Inc (1)
- Arbutus Biopharma Corp (1)
- ARENA PHARMACEUTICALS INC (1)
- Arsanis, Inc. (1)
- ATHERSYS, INC (1)
- Aurinia Pharmaceuticals Inc. (1)
- AVEO PHARMACEUTICALS INC (1)
- Avid Bioservices, Inc. (1)
- AZIYO BIOLOGICS, INC. (1)
- AzurRx BioPharma, Inc. (2)
- BICYCLE THERAPEUTICS Ltd (2)
- BioCardia, Inc. (1)
- Biogen Inc. (1)
- BIOMARIN PHARMACEUTICAL INC (3)
- BIOSPECIFICS TECHNOLOGIES CORP (1)
- BIOTIME INC (1)
- Blue Water Vaccines Inc. (1)
- BRAINSTORM CELL THERAPEUTICS INC. (1)
- Calyxt, Inc. (1)
- CANCER GENETICS, INC (2)
- CATALYST PHARMACEUTICALS, INC. (2)
- Celldex Therapeutics, Inc. (2)
- Celsion CORP (2)
- Chanticleer Holdings, Inc. (1)
- CLEVELAND BIOLABS INC (1)
- Coherus BioSciences, Inc. (2)
- Comera Life Sciences Holdings, Inc. (1)
- CTI BIOPHARMA CORP (2)
- Curative Biotechnology Inc (3)
- CytoDyn Inc. (1)
- CYTORI THERAPEUTICS, INC. (1)
- DelMar Pharmaceuticals, Inc. (1)
- Dicerna Pharmaceuticals Inc (1)
- Diffusion Pharmaceuticals Inc. (3)
- Eagle Pharmaceuticals, Inc. (4)
- ENDONOVO THERAPEUTICS, INC. (1)
- Forty Seven, Inc. (1)
- GENEREX BIOTECHNOLOGY CORP (4)
- GT Biopharma, Inc. (4)
- HedgePath Pharmaceuticals, Inc. (1)
- HUMANIGEN, INC (1)
- iBio, Inc. (1)
- Immune Therapeutics, Inc. (7)
- IMMUNOMEDICS INC (1)
- INFINITY PHARMACEUTICALS, INC. (1)
- Innovation Pharmaceuticals Inc. (1)
- International Stem Cell CORP (1)
- IOVANCE BIOTHERAPEUTICS, INC. (1)
- KBL MERGER CORP. IV (3)
- Kiromic Biopharma, Inc. (2)
- Leisure Acquisition Corp. (1)
- Ligand Pharmaceuticals Incorporated (1)
- MANNKIND CORP (1)
- Merus N.V. (2)
- MiMedx Group, Inc. (1)
- Minerva Neurosciences, Inc. (1)
- Momenta Pharmaceuticals, Inc. (1)
- NANOVIRICIDES, INC. (2)
- NAVIDEA BIOPHARMACEUTICALS, INC. (2)
- NEWLINK GENETICS CORP (1)
- NORTHWEST BIOTHERAPEUTICS INC (2)
- NOVAVAX INC (2)
- Nuo Therapeutics, Inc. (2)
- Opko Health, Inc. (2)
- Orchard Therapeutics plc (1)
- ORGANOVO HOLDINGS, INC. (1)
- Pasithea Therapeutics Corp. (1)
- PDL BIOPHARMA, INC. (3)
- PharmaCyte Biotech, Inc. (1)
- PhaseBio Pharmaceuticals Inc (1)
- PIERIS PHARMACEUTICALS, INC. (1)
- POLARITYTE, INC. (1)
- Progenics Pharmaceuticals, Inc. (2)
- PROGENITY, INC. (15)
- Propanc Biopharma, Inc. (3)
- ProtoKinetix, Inc. (1)
- Regeneron Pharmaceuticals (2)
- REGENXBIO Inc. (1)
- Retrophin, Inc. (1)
- RITTER PHARMACEUTICALS INC (1)
- Sarepta Therapeutics, Inc. (1)
- Savara Inc (1)
- SELLAS Life Sciences Group, Inc. (3)
- SPHERIX INC (3)
- Syndax Pharmaceuticals Inc (1)
- TENAX THERAPEUTICS, INC. (1)
- TG THERAPEUTICS, INC. (1)
- Twist Bioscience Corp (1)
- United Therapeutics Corp (2)
- Vanda Pharmaceuticals Inc. (1)
- Vaxart, Inc. (2)
- VICAL INC (1)
- VITAL THERAPIES INC (1)
- VITRO DIAGNOSTICS INC (2)
- Xenetic Biosciences, Inc. (2)
- XOMA Corp (2)
- Y-mAbs Therapeutics, Inc. (1)
- YIELD10 BIOSCIENCE, INC. (1)
- Settlement Agreement between Immune Therapeutics, Inc. and Jack Brewer dated October 23, 2022 (Immune Therapeutics, Inc., Filed With SEC on April 16, 2024)
- Plan Support and Settlement Agreement, dated as of March 5, 2024, by and between PhaseBio Pharmaceuticals, Inc. and SFJ Pharmaceuticals X, Inc. (f/k/a SFJ Pharmaceuticals X, Ltd.) (PhaseBio Pharmaceuticals Inc, Filed With SEC on March 12, 2024)
- Mutual Release and Settlement Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (VITRO DIAGNOSTICS INC, Filed With SEC on January 29, 2024)
- Settlement Agreement and General Release, dated August 8, 2023, between the Company and SK bioscience Co., Ltd (NOVAVAX INC, Filed With SEC on November 9, 2023)
- Settlement and License Agreement among Coherus BioSciences, Inc., AbbVie Inc. and AbbVie Biotechnology Ltd dated January 24, 2019 (Coherus BioSciences, Inc., Filed With SEC on November 6, 2023)
- Confidential Settlement and License Agreement, dated August 29, 2023, by and among Alkermes, Inc., Alkermes Pharma Ireland Limited and Teva Pharmaceuticals USA, Inc (Alkermes plc., Filed With SEC on October 25, 2023)
- Forbearance, Restructuring and Settlement Agreement, dated as of May 17, 2023, between Athersys, Inc., certain subsidiaries of Athersys, Inc., and (ATHERSYS, INC, Filed With SEC on August 16, 2023)
- Amendment and Settlement Agreement, dated July 20, 2023, by and between Qualigen Therapeutics, Inc. and Nanosynex Ltd (RITTER PHARMACEUTICALS INC, Filed With SEC on July 26, 2023)
- Settlement Agreement between the Company and Statera Biopharma, Inc. dated April 12, 2023 (Immune Therapeutics, Inc., Filed With SEC on April 20, 2023)
- Settlement Agreement, by and between the Registrant, Teva Pharmaceuticals International GmbH, Cephalon, LLC, Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc., dated... (Eagle Pharmaceuticals, Inc., Filed With SEC on April 10, 2023)
- Settlement Agreement between Immune Therapeutics, Inc. and Jack Brewer dated October 23, 2022 (Immune Therapeutics, Inc., Filed With SEC on April 10, 2023)
- Settlement Agreement dated as of December 16, 2022, by and between the Registrant and Catalent Pharma Solutions, LLC (HUMANIGEN, INC, Filed With SEC on March 30, 2023)
- Stipulation and Agreement of Compromise and Settlement dated October 26, 2022 (BIOTIME INC, Filed With SEC on March 9, 2023)
- Mutual Release and Settlement Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (VITRO DIAGNOSTICS INC, Filed With SEC on January 30, 2023)
- Stipulation and Agreement of Compromise, Settlement, and Release, dated September 9, 2022 (HedgePath Pharmaceuticals, Inc., Filed With SEC on December 19, 2022)
- Settlement and Cooperation Agreement dated December 9, 2022, by and between Pasithea Therapeutics Corp. and Camac Fund, LP and its affiliates (Pasithea Therapeutics Corp., Filed With SEC on December 14, 2022)
- Form of Settlement Agreement, by and between the Representative and the Company, dated November 30, 2022 (AzurRx BioPharma, Inc., Filed With SEC on December 2, 2022)
- Settlement Agreement and Release, dated October 9, 2022, by and between the Registrant and Boustead Securities, LLC (Blue Water Vaccines Inc., Filed With SEC on November 14, 2022)
- Settlement and License Agreement, by and between Teva Pharmaceuticals International GmbH (Eagle Pharmaceuticals, Inc., Filed With SEC on November 9, 2022)
- Settlement Agreement, dated September 30, 2022, between the Company and FUJIFILM Diosynth Biotechnologies UK Limited, FUJIFILM Diosynth Biotechnologies Texas, LLC, and FUJIFILM... (NOVAVAX INC, Filed With SEC on November 9, 2022)
- Settlement Agreement dated August 9, 2021 (Curative Biotechnology Inc, Filed With SEC on November 7, 2022)
- Amended Stipulation of Settlement and Mutual Release, dated October 27, 2022, by and among Kiromic Biopharma, Inc., Empery Asset Master, Ltd. and other parties (Kiromic Biopharma, Inc., Filed With SEC on November 2, 2022)
- Settlement and Investment Agreement dated August 24, 2022, by and between GT Biopharma, Inc. and Cytovance Biologics, Inc (GT Biopharma, Inc., Filed With SEC on October 31, 2022)
- Stipulation of Settlement and Mutual Release, dated October 10, 2022, by and among Kiromic Biopharma, Inc., Empery Asset Master, Ltd. and other parties (Kiromic Biopharma, Inc., Filed With SEC on October 14, 2022)
- Settlement Agreement dated August 9, 2021 (Curative Biotechnology Inc, Filed With SEC on September 9, 2022)
- Settlement Agreement dated May 19, 2022, between CytoDyn Inc. and Richard G. Pestell, M.D., Ph.D (CytoDyn Inc., Filed With SEC on August 15, 2022)
- MUTUAL RELEASE AND SETTLEMENT AGREEMENT (Syndax Pharmaceuticals Inc, Filed With SEC on August 8, 2022)
- Confidential Settlement Agreement and Mutual Release, dated July 15, 2022 by and between Shareholder Representatives Services LLC, solely in its capacity as Stockholders... (Celldex Therapeutics, Inc., Filed With SEC on July 18, 2022)
- Settlement Agreement, dated July 14, 2022, by and among OPKO Health, Inc., BioReference Health, LLC, the United States of America, acting through the United States Department of... (Opko Health, Inc., Filed With SEC on July 15, 2022)
- Settlement Agreement, dated July 11, 2022, by and between the Company and SERB SA, on the one hand, and Jacobus Pharmaceutical Company Inc., PantherRx Specialty LLC, and Panther... (CATALYST PHARMACEUTICALS, INC., Filed With SEC on July 12, 2022)
- Binding Settlement Term Sheet, dated June 20, 2022 by and between Shareholder Representatives Services LLC, solely in its capacity as Stockholders Representative, and Celldex... (Celldex Therapeutics, Inc., Filed With SEC on June 23, 2022)
- Settlement and Patent License Agreement, dated February 22, 2022, by and between Organovo Holdings Inc. and BICO Group AB (ORGANOVO HOLDINGS, INC., Filed With SEC on June 10, 2022)
- Settlement and Release Agreement made and entered into as of May 19, 2022, between Comera Life Sciences Holdings, Inc. and Maxim Group LLC (Comera Life Sciences Holdings, Inc., Filed With SEC on May 25, 2022)
- Settlement Agreement dated August 9, 2021 (Curative Biotechnology Inc, Filed With SEC on April 15, 2022)
- Settlement Agreement and Mutual Release, dated November 12, 2021, between the Company and REGENXBIO Inc (ABEONA THERAPEUTICS INC., Filed With SEC on March 31, 2022)
- Settlement Agreement and Mutual General Release among the Company, Dr. Lynn Kirkpatrick, DelMorgan Group LLC and Globalist Capital LLC, dated August 3, 2021 (Leisure Acquisition Corp., Filed With SEC on March 31, 2022)
- Settlement Agreement and Mutual Release, dated March 11, 2022 by and between the Company and BSLF, LLC (BioCardia, Inc., Filed With SEC on March 29, 2022)
- Settlement Agreement and Mutual Release dated November 12, 2021 between the Registrant and Abeona Therapeutics Inc (REGENXBIO Inc., Filed With SEC on March 1, 2022)
- Amendment to License Agreement and Settlement, dated November 1, 2021, between ARES TRADING SA and Sonnet BioTherapeutics CH SA (Chanticleer Holdings, Inc., Filed With SEC on December 17, 2021)
- Settlement Agreement, by and between the Company and Fortis Advisors LLC, dated November 15, 2021 (AzurRx BioPharma, Inc., Filed With SEC on November 16, 2021)
